Alzheimer's disease clinical trials are pivotal in the ongoing battle against dementia. These trials test new treatments and therapies aimed at slowing or halting the progression of Alzheimer's, a degenerative brain disorder that impairs memory and cognitive functions. Researchers recruit participants to evaluate the safety and efficacy of experimental drugs or interventions, often comparing them to placebos or standard treatments. The goal is to discover breakthroughs that can improve quality of life for those affected by Alzheimer's and possibly find a cure. Participation in clinical trials not only offers potential benefits to patients but also advances scientific understanding of the disease. It's crucial for participants to be well-informed about the risks and potential outcomes before deciding to join, contributing to the collective effort in finding effective treatments for Alzheimer's disease.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States